Form 4 holding
10%+ Owner
NewAmsterdam Pharma Co N.V.
- Security class
- Ordinary Shares
- Shares / value
- 10,473,913
- Estimated value
- $199,004,347
- Report date
- 29 Dec 2023
- Price
- $19.00
- Ownership
- Indirect
Bain Capital Life Sciences Investors, LLC - 10%+ Owner at NewAmsterdam Pharma Co N.V.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- NAMS, NAMSW on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Bain Capital Life Sciences Investors, LLC since 21 Oct 2025
Reported holdings for Bain Capital Life Sciences Investors, LLC in NewAmsterdam Pharma Co N.V.
Form 4 holding
10%+ Owner
NewAmsterdam Pharma Co N.V.
- Security class
- Pre-Funded Warrant (right to buy)
- Shares / value
- 1,632,653
- Estimated value
- $39,999,835
- Report date
- 13 Dec 2024
- Price
- $24.50
- Ownership
- Indirect
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Bain Capital Life Sciences Investors, LLC in NewAmsterdam Pharma Co N.V.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.